Literature DB >> 26665121

The Harvard Automated Phone Task: new performance-based activities of daily living tests for early Alzheimer's disease.

Gad A Marshall1, Maria Dekhtyar2, Jonathan M Bruno2, Kamal Jethwani3, Rebecca E Amariglio1, Keith A Johnson4, Reisa A Sperling1, Dorene M Rentz1.   

Abstract

BACKGROUND: Impairment in activities of daily living is a major burden for Alzheimer's disease dementia patients and caregivers. Multiple subjective scales and a few performance-based instruments have been validated and proven to be reliable in measuring instrumental activities of daily living in Alzheimer's disease dementia but less so in amnestic mild cognitive impairment and preclinical Alzheimer's disease.
OBJECTIVE: To validate the Harvard Automated Phone Task, a new performance-based activities of daily living test for early Alzheimer's disease, which assesses high level tasks that challenge seniors in daily life.
DESIGN: In a cross-sectional study, the Harvard Automated Phone Task was associated with demographics and cognitive measures through univariate and multivariate analyses; ability to discriminate across diagnostic groups was assessed; test-retest reliability with the same and alternate versions was assessed in a subset of participants; and the relationship with regional cortical thickness was assessed in a subset of participants.
SETTING: Academic clinical research center. PARTICIPANTS: One hundred and eighty two participants were recruited from the community (127 clinically normal elderly and 45 young normal participants) and memory disorders clinics at Brigham and Women's Hospital and Massachusetts General Hospital (10 participants with mild cognitive impairment). MEASUREMENTS: As part of the Harvard Automated Phone Task, participants navigated an interactive voice response system to refill a prescription (APT-Script), select a new primary care physician (APT-PCP), and make a bank account transfer and payment (APT-Bank). The 3 tasks were scored based on time, errors, and repetitions from which composite z-scores were derived, as well as a separate report of correct completion of the task.
RESULTS: We found that the Harvard Automated Phone Task discriminated well between diagnostic groups (APT-Script: p=0.002; APT-PCP: p<0.001; APT-Bank: p=0.02), had an incremental level of difficulty, and had excellent test-retest reliability (Cronbach's α values of 0.81 to 0.87). Within the clinically normal elderly, there were significant associations in multivariate models between performance on the Harvard Automated Phone Task and executive function (APT-PCP: p<0.001), processing speed (APT-Script: p=0.005), and regional cortical atrophy (APT-PCP: p=0.001; no significant association with APT-Script) independent of hearing acuity, motor speed, age, race, education, and premorbid intelligence.
CONCLUSIONS: Our initial experience with the Harvard Automated Phone Task, which consists of ecologically valid, easily-administered measures of daily activities, suggests that these tasks could be useful for screening and tracking the earliest functional alterations in preclinical and early prodromal AD.

Entities:  

Keywords:  Alzheimer’s disease; activities of daily living; mild cognitive impairment; performance-based; validation

Year:  2015        PMID: 26665121      PMCID: PMC4671513          DOI: 10.14283/jpad.2015.72

Source DB:  PubMed          Journal:  J Prev Alzheimers Dis        ISSN: 2274-5807


  27 in total

1.  Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain.

Authors:  Bruce Fischl; David H Salat; Evelina Busa; Marilyn Albert; Megan Dieterich; Christian Haselgrove; Andre van der Kouwe; Ron Killiany; David Kennedy; Shuna Klaveness; Albert Montillo; Nikos Makris; Bruce Rosen; Anders M Dale
Journal:  Neuron       Date:  2002-01-31       Impact factor: 17.173

2.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

3.  Neural correlates of impaired functional independence in early Alzheimer's disease.

Authors:  Eric D Vidoni; Robyn A Honea; Jeffrey M Burns
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 4.  The cognitive correlates of functional status: a review from the Committee on Research of the American Neuropsychiatric Association.

Authors:  Donald R Royall; Edward C Lauterbach; Daniel Kaufer; Paul Malloy; Kerry L Coburn; Kevin J Black
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2007       Impact factor: 2.198

5.  Functional correlates of instrumental activities of daily living in mild Alzheimer's disease.

Authors:  Neelesh K Nadkarni; Naama Levy-Cooperman; Sandra E Black
Journal:  Neurobiol Aging       Date:  2010-03-31       Impact factor: 4.673

6.  Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI.

Authors:  Susan M Landau; Danielle Harvey; Cindee M Madison; Robert A Koeppe; Eric M Reiman; Norman L Foster; Michael W Weiner; William J Jagust
Journal:  Neurobiol Aging       Date:  2009-08-05       Impact factor: 4.673

7.  Validity of direct assessment of functional status as a tool for measuring Alzheimer's disease severity.

Authors:  O Zanetti; G B Frisoni; L Rozzini; A Bianchetti; M Trabucchi
Journal:  Age Ageing       Date:  1998-09       Impact factor: 10.668

8.  Performance-Based instrument to assess functional capacity in dementia: The Texas Functional Living Scale.

Authors:  C M Cullum; K Saine; L D Chan; K Martin-Cook; K F Gray; M F Weiner
Journal:  Neuropsychiatry Neuropsychol Behav Neurol       Date:  2001 Apr-Jun

9.  Regional rates of neocortical atrophy from normal aging to early Alzheimer disease.

Authors:  C R McDonald; L K McEvoy; L Gharapetian; C Fennema-Notestine; D J Hagler; D Holland; A Koyama; J B Brewer; A M Dale
Journal:  Neurology       Date:  2009-08-11       Impact factor: 9.910

10.  Declining financial capacity in mild cognitive impairment: A 1-year longitudinal study.

Authors:  K L Triebel; R Martin; H R Griffith; J Marceaux; O C Okonkwo; L Harrell; D Clark; J Brockington; A Bartolucci; Daniel C Marson
Journal:  Neurology       Date:  2009-09-22       Impact factor: 9.910

View more
  11 in total

1.  Editorial: Preventive Trials for Alzheimer's Diseases: The Multi-domain and the Targeted Therapies Approaches Will Have to Be Associated.

Authors:  J Lin; B Dong; B Vellas
Journal:  J Nutr Health Aging       Date:  2016       Impact factor: 4.075

2.  EU/US/CTAD Task Force: Lessons Learned from Recent and Current Alzheimer's Prevention Trials.

Authors:  P Aisen; J Touchon; R Amariglio; S Andrieu; R Bateman; J Breitner; M Donohue; B Dunn; R Doody; N Fox; S Gauthier; M Grundman; S Hendrix; C Ho; M Isaac; R Raman; P Rosenberg; R Schindler; L Schneider; R Sperling; P Tariot; K Welsh-Bohmer; M Weiner; B Vellas
Journal:  J Prev Alzheimers Dis       Date:  2017

Review 3.  Amyloid Accumulation and Cognitive Decline in Clinically Normal Older Individuals: Implications for Aging and Early Alzheimer's Disease.

Authors:  Elizabeth C Mormino; Kathryn V Papp
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

4.  Activities of daily living measured by the Harvard Automated Phone Task track with cognitive decline over time in non-demented elderly.

Authors:  Gad A Marshall; Sarah L Aghjayan; Maria Dekhtyar; Joseph J Locascio; Kamal Jethwani; Rebecca E Amariglio; Keith A Johnson; Reisa A Sperling; Dorene M Rentz
Journal:  J Prev Alzheimers Dis       Date:  2017

5.  Clinical Utility of Select Neuropsychological Assessment Battery Tests in Predicting Functional Abilities in Dementia.

Authors:  Lee Ashendorf; Michael L Alosco; Hanaan Bing-Canar; Kimberly R Chapman; Brett Martin; Christine E Chaisson; Diane Dixon; Eric G Steinberg; Yorghos Tripodis; Neil W Kowall; Robert A Stern
Journal:  Arch Clin Neuropsychol       Date:  2018-08-01       Impact factor: 2.813

Review 6.  Measuring cognition and function in the preclinical stage of Alzheimer's disease.

Authors:  Sandra Weintraub; Maria C Carrillo; Sarah Tomaszewski Farias; Terry E Goldberg; James A Hendrix; Judith Jaeger; David S Knopman; Jessica B Langbaum; Denise C Park; Michael T Ropacki; Sietske A M Sikkes; Kathleen A Welsh-Bohmer; Lisa J Bain; Robert Brashear; Kumar Budur; Ana Graf; Ferenc Martenyi; Marta Segardahl Storck; Christopher Randolph
Journal:  Alzheimers Dement (N Y)       Date:  2018-02-13

7.  Measuring instrumental activities of daily living in non-demented elderly: a comparison of the new performance-based Harvard Automated Phone Task with other functional assessments.

Authors:  Gad A Marshall; Sarah L Aghjayan; Maria Dekhtyar; Joseph J Locascio; Kamal Jethwani; Rebecca E Amariglio; Sara J Czaja; David A Loewenstein; Keith A Johnson; Reisa A Sperling; Dorene M Rentz
Journal:  Alzheimers Res Ther       Date:  2019-01-10       Impact factor: 6.982

8.  Instrumental activities of daily living, amyloid, and cognition in cognitively normal older adults screening for the A4 Study.

Authors:  Gad A Marshall; Sietske A M Sikkes; Rebecca E Amariglio; Jennifer R Gatchel; Dorene M Rentz; Keith A Johnson; Oliver Langford; Chung-Kai Sun; Michael C Donohue; Rema Raman; Paul S Aisen; Reisa A Sperling; Douglas R Galasko
Journal:  Alzheimers Dement (Amst)       Date:  2020-10-30

9.  Informant Reporting in Mild Cognitive Impairment: Sources of Discrepancy on the Functional Activities Questionnaire.

Authors:  Katherine Hackett; Rachel Mis; Deborah A G Drabick; Tania Giovannetti
Journal:  J Int Neuropsychol Soc       Date:  2020-01-22       Impact factor: 2.892

10.  Decline in cognitively complex everyday activities accelerates along the Alzheimer's disease continuum.

Authors:  Mark A Dubbelman; Roos J Jutten; Sarah E Tomaszewski Farias; Rebecca E Amariglio; Rachel F Buckley; Pieter Jelle Visser; Dorene M Rentz; Keith A Johnson; Michael J Properzi; Aaron Schultz; Nancy Donovan; Jennifer R Gatchell; Charlotte E Teunissen; Bart N M Van Berckel; Wiesje M Van der Flier; Reisa A Sperling; Kathryn V Papp; Philip Scheltens; Gad A Marshall; Sietske A M Sikkes
Journal:  Alzheimers Res Ther       Date:  2020-10-29       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.